Recurrent Genital Herpes Simplex Type 2: Clinical Trials

2 completed. 2 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	2	Completed 2

Follow Recurrent Genital Herpes Simplex Type 2: new trials by email Literature Review of Recurrent Genital Herpes Simplex Type 2 trials Research Report on Recurrent Genital Herpes Simplex Type 2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes ABI-1179, ABI-1179 Placebo - Recurrent Genital Herpes Simplex Type 2	Phase 1	Completed	Assembly Biosciences	103	2024-12-08	2026-03-23
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes ABI-5366, ABI-5366 Placebo - Recurrent Genital Herpes Simplex Type 2	Phase 1	Completed	Assembly Biosciences	115	2024-05-30	2026-03-30

Narrower conditions

Herpes Genitalis (2)

Broader conditions

Communicable Diseases (2)  ·  DNA Virus Infections (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Diseases, Male (2)  ·  Herpes Simplex (2)  ·  Herpesviridae Infections (2)  ·  Infections (2)  ·  Male Urogenital Diseases (2)  ·  Sexually Transmitted Diseases (2)  ·  Sexually Transmitted Diseases, Viral (2)  ·  Urogenital Diseases (2)  ·  Virus Diseases (2)

Sponsors

Assembly Biosciences (2)

Countries

Australia (2)  ·  New Zealand (2)  ·  United States (1)